Physical and Biological Characteristics of Particle Therapy for Oncologists

키워드

참고문헌 (57)

1. Halperin EC, "Particle therapy and treatment of cancer", Lancet Oncol, 7, pp.676~685 (2006)
2. Slater JM, "The proton treatment center at Loma Linda University Medical Center : rationale for and description of its development", Int J Radiat Oncol Biol Phys, 22, pp.383~389 (1992)
3. Tsuji H, "Proton radiotherapy : clinical experience and outcome at Tsukuba", Radiol Nuclear Med, 43, pp.604~609 (1997)
4. Schaub L, "Particle therapy in the future of precision therapy", Br J Radiol, 93, pp.20200183~ (2020)
5. Patel SH, "Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases : a systematic review and meta-analysis", Lancet Oncol, 15, pp.1027~1038 (2014)
6. "Particle therapy facilities in clinical operation (last update Feb 2021)" (2021)[URL]
7. "Particle therapy facilities under construction (last update Feb 2021)" (2021)[URL]
8. Campian JL, "Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer", Head Neck, 36, pp.1747~1753 (2014)
9. Mohan R, "Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients : phase II randomized study of protons vs photons", Neuro Oncol, 23, pp.284~294 (2021)
10. Routman DM, "A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer", Adv Radiat Oncol, 4, pp.63~69 (2019)
11. Xiang M, "Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy", Cancer, 126, pp.3560~3568 (2020)
12. Mohamad O, "Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer : a propensity score-weighted, retrospective, cohort study", Lancet Oncol, 20, pp.674~685 (2019)
13. Saunders W, "Helium-ion radiation therapy at the Lawrence Berkeley Laboratory : recent results of a Northern California Oncology Group Clinical Trial", Radiat Res Suppl, 8, pp.S227~34 (1985)
14. Tessonnier T, "Helium ions at the heidelberg ion beam therapy center : comparisons between FLUKA Monte Carlo code predictions and dosimetric measurements", Phys Med Biol, 62, pp.6784~6803 (2017)
15. Tobias CA, "Radiological use of high energy deuterons and alpha particles", Am J Roentgenol Radium Ther Nucl Med, 67, pp.1~27 (1952)
16. Lawrence JH, "Pituitary irradiation with high-energy proton beams : a preliminary report", Cancer Res, 18, pp.121~134 (1958)
17. Castro JR, "Radiotherapy with heavy charged particles at Lawrence Berkeley Laboratory", J Can Assoc Radiol, 31, pp.30~34 (1980)
18. Chen GT, "Heavy charged particle radiotherapy", Annu Rev Biophys Bioeng, 10, pp.499~529 (1981)
19. Chatterjee A, "High energy beams of radioactive nuclei and their biomedical applications", Int J Radiat Oncol Biol Phys, 7, pp.503~507 (1981)
20. "Particle Therapy Co-Operative Group" (2021)[URL]
21. Tsujii H, "Carbon-ion radiotherapy: principles, practices, and treatment planning" (2014), Springer
22. Fredriksson A, "Advances and trends in optimization with engineering applications", pp.1~12 (2017), SIAM
23. 한영이, "Current status of proton therapy techniques for lung cancer", Radiation oncology journal, 37(4), pp.232~248 (2019), 대한방사선종양학회
24. Seco J, "Breathing interplay effects during proton beam scanning : simulation and statistical analysis", Phys Med Biol, 54, pp.N283~94 (2009)
25. Yoo GS, "Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma", Radiother Oncol, 146, pp.187~193 (2020)
26. Hall EJ, "Radiobiology for the radiologist", pp.394~396 (2010), Lippincott Williams & Wolters Kluwer
27. Paganetti H, "Relative biological effectiveness(RBE)values for proton beam therapy", Int J Radiat Oncol Biol Phys, 53, pp.407~421 (2002)
28. Choi C, "Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction", PLoS One, 14, pp.e0218049~ (2019)
29. Jones B, "Towards achieving the full clinical potential of proton therapy by inclusion of LET and RBE models", Cancers(Basel), 7, pp.460~480 (2015)
30. Paganetti H, "Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy", Med Phys, 46, pp.e53~78 (2019)
31. Bristow RG, "Hypoxia and metabolism : hypoxia, DNA repair and genetic instability", Nat Rev Cancer, 8, pp.180~192 (2008)
32. Brown JM, "Exploiting tumour hypoxia in cancer treatment", Nat Rev Cancer, 4, pp.437~447 (2004)
33. West C, "Establishment of a radiogenomics consortium", Int J Radiat Oncol Biol Phys, 76, pp.1295~1296 (2010)
34. Fachal L, "A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1", Nat Genet, 46, pp.891~894 (2014)
35. Kerns SL, "Meta-analysis of genome wide association studies identifies genetic markers of late toxicity following radiotherapy for prostate cancer", EBioMedicine, 10, pp.150~163 (2016)
36. Tinganelli W, "Carbon ion radiobiology", Cancers(Basel), 12, pp.3022~ (2020)
37. West C, "Translational radiobiology: radiogenomics", Proceedings of the PTCOG-58 (2019)
38. Akino Y, "Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells", Int J Radiat Oncol Biol Phys, 75, pp.475~481 (2009)
39. Kamlah F, "Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma cells", Int J Radiat Oncol Biol Phys, 80, pp.1541~1549 (2011)
40. Moncharmont C, "Radiation-enhanced cell migration", invasion process : a review, 2014, pp.92, 133~142
41. Sonveaux P, "Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway : implications for tumor radiotherapy", Cancer Res, 63, pp.1012~1019 (2003)
42. Wild-Bode C, "Sublethal irradiation promotes migration and invasiveness of glioma cells : implications for radiotherapy of human glioblastoma", Cancer Res, 61, pp.2744~2750 (2001)
43. Ogata T, "Particle irradiation suppresses metastatic potential of cancer cells", Cancer Res, 65, pp.113~120 (2005)
44. Takahashi Y, "Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose", Cancer Res, 63, pp.4253~4257 (2003)
45. Subtil FS, "Carbon ion radiotherapy of human lung cancer attenuates HIF-1 signaling and acts with considerably enhanced therapeutic efficiency", FASEB J, 28, pp.1412~1421 (2014)
46. Sharif S, "Second primary tumors in neurofibromatosis 1 patients treated for optic glioma : substantial risks after radiotherapy", J Clin Oncol, 24, pp.2570~2575 (2006)
47. Hodi FS, "Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma : 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial", Lancet Oncol, 17, pp.1558~1568 (2016)
48. Wolchok JD, "Overall survival with combined nivolumab and ipilimumab in advanced melanoma", N Engl J Med, 377, pp.1345~1356 (2017)
49. Robert C, "Nivolumab in previously untreated melanoma without BRAF mutation", N Engl J Med, 372, pp.320~330 (2015)
50. Robert C, "Pembrolizumab versus ipilimumab in advanced melanoma", N Engl J Med, 372, pp.2521~2532 (2015)
51. Demaria S, "Role of local radiation therapy in cancer immunotherapy", JAMA Oncol, 1, pp.1325~1332 (2015)
52. Gameiro SR, "Tumor cells surviving exposure to proton or photon radiation share a common immunogenic modulation signature, rendering them more sensitive to T cell-mediated killing", Int J Radiat Oncol Biol Phys, 95, pp.120~130 (2016)
53. Bouquet F, "The loss of gammaH2AX signal is a marker of DNA double strand breaks repair only at low levels of DNA damage", Cell Cycle, 5, pp.1116~1122 (2006)
54. Sato H, "DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells", Nat Commun, 8, pp.1751~ (2017)
55. Schmid TE, "Non-targeted effects of photon and particle irradiation and the interaction with the immune system", Front Oncol, 2, pp.80~ (2012)
56. Matsunaga A, "Carbon-ion beam treatment induces systemic antitumor immunity against murine squamous cell carcinoma", Cancer, 116, pp.3740~3748 (2010)
57. Ando K, "Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation", J Radiat Res, 58, pp.446~455 (2017)

관련 논문AI추천